In addition to physical barriers, neutrophils are considered a part of the first line of immune
defense. They can be found in the bloodstream, with a lifespan of 6–8 h, and in tissue …

Abstract In 2009 the first European Society of Clinical Microbiology and Infection (ESCMID)
treatment guidance document for Clostridium difficile infection (CDI) was published. The …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Background & Aims Fecal microbiota transplantation (FMT) is recommended for treatment of
recurrent Clostridium difficile infection (rCDI). We performed a single-center randomized trial …

Importance Clostridium difficileinfection (CDI) is a major burden in health care and
community settings. CDI recurrence is of particular concern because of limited treatment …

Importance Since 2000, the incidence and severity ofClostridium difficileinfection (CDI) have
increased. Objective To review current evidence regarding best practices for the diagnosis …

Clostridium difficileinfection (CDI) is a leading cause of hospital-associated gastrointestinal
illness and places a high burden on our health-care system. Patients with CDI typically have …

The most common cause of antibiotic-associated diarrhea is Clostridium difficile infection
(CDI). Recurrent C. difficile infection (rCDI) often occurs after successful treatment of CDI …

OBJECTIVES: While fecal microbiota transplantation (FMT) is historically known to be an
effective means to treat recurrentClostridium difficileinfection (CDI) refractory to standard …